Generation of Two HiPSC Lines, (DMBi003-A and DMBi004-A), by Reprogramming Peripheral Blood Mononuclear Cells and Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients
Overview
Authors
Affiliations
Rheumatoid arthritis (RA) is a chronic inflammatory disease that primarily affects joints but should be considered as a syndrome that also includes extra-articular manifestations and comorbidities. Human-derived induced pluripotent stem cells (hiPSCs) and their differentiated derivatives may be of special interest in the investigation of complex pathophysiology of RA. In this study, we demonstrate and compare the generation of hiPSC from peripheral blood mononuclear cells (PBMC) and fibroblast-like synoviocytes (FLS) from RA patients. Application of three-dimensional cardiac microtissues constructed from RA specific iPSC-derivatives may be a useful approach to investigate RA comorbidities and cardiac protection or toxicity of anti-rheumatic drugs.
Wolnik J, Adamska P, Oleksy A, Sanetra A, Palus-Chramiec K, Lewandowski M Stem Cell Res Ther. 2024; 15(1):382.
PMID: 39468575 PMC: 11520781. DOI: 10.1186/s13287-024-03956-1.
Research progress of autoimmune diseases based on induced pluripotent stem cells.
Ren R, Jiang J, Li X, Zhang G Front Immunol. 2024; 15():1349138.
PMID: 38720903 PMC: 11076788. DOI: 10.3389/fimmu.2024.1349138.
Investigation of immune-related diseases using patient-derived induced pluripotent stem cells.
Shoda H, Natsumoto B, Fujio K Inflamm Regen. 2023; 43(1):51.
PMID: 37876023 PMC: 10594759. DOI: 10.1186/s41232-023-00303-4.
Eremeev A, Pikina A, Ruchko Y, Bogomazova A Int J Mol Sci. 2023; 24(19).
PMID: 37833856 PMC: 10572671. DOI: 10.3390/ijms241914408.